Nomura Asset Management Co. Ltd. Buys 1,731 Shares of Equifax, Inc. $EFX

Nomura Asset Management Co. Ltd. raised its stake in Equifax, Inc. (NYSE:EFX) by 4.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 40,546 shares of the credit services provider’s stock after purchasing an additional 1,731 shares during the period. Nomura Asset Management Co. Ltd.’s holdings in Equifax were worth $10,516,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Alberta Investment Management Corp bought a new stake in shares of Equifax during the 2nd quarter worth about $2,049,000. Citizens Financial Group Inc. RI acquired a new stake in Equifax during the second quarter worth approximately $207,000. Cetera Investment Advisers boosted its holdings in shares of Equifax by 6.0% during the second quarter. Cetera Investment Advisers now owns 16,509 shares of the credit services provider’s stock worth $4,282,000 after acquiring an additional 941 shares during the period. Creative Planning grew its position in shares of Equifax by 1.6% in the second quarter. Creative Planning now owns 35,600 shares of the credit services provider’s stock valued at $9,234,000 after purchasing an additional 557 shares during the last quarter. Finally, SG Americas Securities LLC grew its position in shares of Equifax by 303.9% in the second quarter. SG Americas Securities LLC now owns 21,120 shares of the credit services provider’s stock valued at $5,478,000 after purchasing an additional 15,891 shares during the last quarter. Institutional investors and hedge funds own 96.20% of the company’s stock.

Equifax Stock Performance

EFX opened at $205.98 on Thursday. The company has a debt-to-equity ratio of 0.82, a quick ratio of 0.74 and a current ratio of 0.74. Equifax, Inc. has a 52-week low of $199.98 and a 52-week high of $281.07. The firm has a market cap of $25.21 billion, a P/E ratio of 39.09, a price-to-earnings-growth ratio of 2.41 and a beta of 1.64. The business’s fifty day moving average is $231.75 and its 200-day moving average is $247.87.

Equifax (NYSE:EFX) last posted its quarterly earnings results on Tuesday, October 21st. The credit services provider reported $2.04 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.10. Equifax had a return on equity of 19.28% and a net margin of 11.08%.The business had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.52 billion. During the same quarter in the previous year, the firm earned $1.85 earnings per share. Equifax’s revenue for the quarter was up 7.2% compared to the same quarter last year. Equifax has set its Q4 2025 guidance at 1.980-2.080 EPS. FY 2025 guidance at 7.550-7.650 EPS. Sell-side analysts expect that Equifax, Inc. will post 7.58 EPS for the current fiscal year.

Equifax Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, December 15th. Stockholders of record on Monday, November 24th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Monday, November 24th. Equifax’s dividend payout ratio is 37.95%.

Insider Activity at Equifax

In other Equifax news, CEO Mark W. Begor sold 21,386 shares of the company’s stock in a transaction on Monday, October 27th. The stock was sold at an average price of $231.12, for a total transaction of $4,942,732.32. Following the completion of the sale, the chief executive officer directly owned 22,045 shares in the company, valued at $5,095,040.40. This represents a 49.24% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Jamil Farshchi sold 4,925 shares of the firm’s stock in a transaction on Monday, October 27th. The shares were sold at an average price of $238.94, for a total value of $1,176,779.50. Following the completion of the sale, the executive vice president directly owned 39,364 shares in the company, valued at approximately $9,405,634.16. This represents a 11.12% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 54,270 shares of company stock worth $12,580,837 in the last quarter. 1.40% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

EFX has been the subject of several research reports. JPMorgan Chase & Co. dropped their price target on Equifax from $277.00 to $272.00 and set an “overweight” rating for the company in a report on Wednesday, July 23rd. BMO Capital Markets dropped their target price on Equifax from $251.00 to $245.00 and set a “market perform” rating for the company in a report on Wednesday, October 22nd. Barclays reduced their target price on shares of Equifax from $260.00 to $240.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 23rd. Stifel Nicolaus decreased their price target on shares of Equifax from $295.00 to $253.00 and set a “buy” rating on the stock in a research note on Wednesday, October 22nd. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $295.00 price objective on shares of Equifax in a research note on Tuesday, October 21st. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $277.13.

Equifax Profile

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.